[fcb5af]: / literature / by_gene / PAX5.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 29263590 10.14202/vetworld.2017.1307-1313 2022 Immunocytochemical study of canine lymphomas and its correlation with exposure to tobacco smoke. PAX5
2 29296913 10.1182/bloodadvances.2017009472 2022 Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. PAX5
3 33398683 10.1007/s12105-020-01276-3 2022 Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase Negative Anaplastic Large Cell Lymphoma in a Geriatric Patient-Report of a Rare Case. PAX5
4 34049715 10.1016/j.pathol.2021.02.013 2022 Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosis. PAX5
5 34190415 10.1002/dc.24821 2022 ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: A diagnostic pitfall. PAX5
6 34282671 10.1177/03009858211030523 2022 Histopathological features and immunophenotyping of canine transmural gastrointestinal lymphoma using full-thickness biopsy samples. PAX5
7 34310368 10.1097/PAS.0000000000001785 2022 Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas. PAX5
8 34371436 10.1016/j.leukres.2021.106683 2022 Proposal and clinical application of molecular genetic risk scoring system, MRplus, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre. PAX5
9 34374890 10.1007/s12029-021-00662-6 2022 Primary ALK-Positive Large B Cell Lymphoma of Pancreas. PAX5
10 34499743 10.1111/1556-4029.14879 2022 Sudden death in an adolescent due to undiagnosed classic Hodgkin lymphoma. PAX5
11 34547766 10.1182/bloodadvances.2021004895 2022 Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia. PAX5
12 34560683 10.1097/PAS.0000000000001813 2022 A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. PAX5
13 34591292 10.1007/s12185-021-03229-0 2022 Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation. PAX5
14 34657128 10.1038/s41375-021-01448-2 2022 Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. PAX5
15 34707037 10.3960/jslrt.21025 2022 t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma. PAX5
16 34747234 10.1177/00031348211054526 2022 Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder. PAX5
17 34753926 10.1038/s41408-021-00570-9 2022 Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes. PAX5
18 34787376 10.1002/cnr2.1587 2022 Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia. PAX5
19 34801601 10.1016/j.humpath.2021.11.007 2022 Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma. PAX5
20 34872475 10.2174/1566524021666211206094046 2022 PAX5 Haploinsufficiency Induces Low T Cell Infiltration in the Cancer Microenvironment via Reduced Chemokines. PAX5
21 34896889 10.1016/j.anndiagpath.2021.151868 2022 Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls. PAX5
22 34907175 10.1038/s41467-021-27197-5 2022 Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia. PAX5
23 34910327 10.1111/jop.13269 2022 Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases. PAX5
24 34924212 10.1016/j.pathol.2021.09.019 2022 Monocytoid switch in an adult with B-cell precursor acute lymphoblastic leukaemia characterised by the PAX5 P80R mutation. PAX5
25 34933343 10.1182/bloodadvances.2021005634 2022 Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. PAX5
26 34940123 10.3390/cimb43030149 2022 Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression. PAX5
27 34957727 10.2478/raon-2021-0050 2022 Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience. PAX5
28 34981542 10.1111/cup.14196 2022 Immunohistochemistry of the oncofetal protein IMP3 is helpful in the diagnosis of intravascular large B-cell lymphoma using skin biopsy. PAX5
29 35004601 10.3389/fpubh.2021.805757 2022 Risk Factors for Childhood Leukemia: Radiation and Beyond. PAX5
30 35011638 10.3390/cells11010076 2022 Pax-5 Protein Expression Is Regulated by Transcriptional 3'UTR Editing. PAX5
31 35013921 10.1007/s12029-021-00790-z 2022 Spindle Variant Primary Diffuse Large B Cell Lymphoma of the Colon: Case Report and Literature Review. PAX5
32 35067515 10.1097/PAS.0000000000001828 2022 Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature. PAX5
33 35091549 10.1038/s41408-022-00616-6 2022 Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? PAX5
34 35131871 10.1158/0008-5472.CAN-21-3386 2022 Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice. PAX5
35 35179642 10.1007/s00277-021-04394-2 2022 CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression-a potential differential diagnostic pitfall between PTLD and PTSMT. PAX5
36 35192684 10.1182/blood.2022015444 2022 Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. PAX5
37 35205758 10.3390/cancers14041010 2022 Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. PAX5
38 35226982 10.31083/j.fbl2702039 2022 Cytofluorimetric assay to investigate variability in blinatumomab <i>in vitro</i> response. PAX5
39 35231988 10.3760/cma.j.issn.0253-2727.2022.01.005 2022 [Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology]. PAX5
40 35245931 10.1182/bloodadvances.2021006328 2022 Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping. PAX5
41 35264043 10.1177/10406387221078608 2022 Pax5 and CD3 immunophenotyping of lymphoma in 2 central bearded dragons. PAX5
42 35264486 10.11405/nisshoshi.119.227 2022 [Endoscopic mucosal resection of localized plasmablastic lymphoma with early rectal cancer:a rare case report and literature review]. PAX5
43 35286176 10.1080/15513815.2022.2050325 2022 A Curious Case of Morphologically Deceptive Pediatric B-Lymphoblastic Leukemia with Granular Blebbed Blasts and DLBCL-Like Biopsy Findings. PAX5
44 35307403 10.1016/j.humpath.2022.03.005 2022 CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: a histopathological study of 118 cases. PAX5
45 35322462 10.1111/his.14652 2022 Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma. PAX5
46 35395675 10.1093/carcin/bgac034 2022 Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans. PAX5
47 35409379 10.3390/ijms23074021 2022 Hypermethylation-Mediated Silencing of <i>CIDEA</i>, <i>MAL</i> and <i>PCDH17</i> Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies. PAX5
48 35442117 10.1177/10406387221090281 2022 Primary nervous system lymphoma in cats. PAX5
49 35448666 10.3390/vetsci9040168 2022 Bcl-2 Immunoexpression in Feline Epitheliotropic Intestinal T-Cell Lymphomas. PAX5
50 35460405 10.1093/ajcp/aqac044 2022 IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas. PAX5
51 35467057 10.1111/cas.15380 2022 PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch. PAX5
52 35512254 10.1093/ajcp/aqab179 2022 The Effectiveness of Dual-Staining Immunohistochemistry in the Detection of Mantle Cell Lymphoma in the Bone Marrow. PAX5
53 35521914 10.1177/10668969221099627 2022 ALK-positive Large B-Cell Lymphoma Presenting as a Circumscribed Breast Mass with Germinal Center Immunophenotype. PAX5
54 35523507 10.1136/bcr-2021-247430 2022 Epstein-Barr virus-positive mucocutaneous ulcer, plasmablastic type, associated with nodal CD4+ angioimmunoblastic T-cell lymphoma and generalised pruritus: a self-limiting lymphoproliferative disorder resembling cutaneous plasmablastic lymphoma. PAX5
55 35562413 10.1038/s41379-022-01091-x 2022 Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics. PAX5
56 35562965 10.3390/ijms23094574 2022 Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia. PAX5
57 35575765 10.1097/PAS.0000000000001917 2022 Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D. PAX5
58 35600178 10.1016/j.amsu.2022.103786 2022 Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study. PAX5
59 35646671 10.3389/fonc.2022.883141 2022 Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature. PAX5
60 35664405 10.7759/cureus.24592 2022 Primary Endometrial Diffuse Large B-cell Lymphoma: A Rare Disease and Diagnostic Challenge in an Asymptomatic Postmenopausal Woman. PAX5
61 35673721 10.3760/cma.j.cn112151-20211117-00836 2022 [ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases]. PAX5
62 35774514 10.3389/fgene.2022.827840 2022 A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma. PAX5
63 35789115 10.1111/his.14718 2022 Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia. PAX5
64 35864305 10.1038/s41698-022-00295-3 2022 Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma. PAX5
65 35911381 10.3389/fmed.2022.896647 2022 Thymic Extranodal Marginal-Zone Lymphoma of Mucosa-Associated Lymphoid Tissue: Pathological Features, <sup>18</sup>F-FDG PET/CT Findings and Prognosis in 12 Cases. PAX5
66 35920299 10.1096/fj.202200061RR 2022 Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context. PAX5
67 35926290 10.1016/j.anndiagpath.2022.151974 2022 The utility of PAX8 in comparison with PAX5 immunohistochemical staining in the diagnosis of Hodgkin lymphoma. PAX5
68 35949809 2022 Transient atypical lymphoplasmacytic proliferation of the endometrium associated with pyometra: a case report. PAX5
69 35977101 10.1182/blood.2022016056 2022 Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma. PAX5
70 35979119 10.12998/wjcc.v10.i17.5708 2022 Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report. PAX5
71 35987347 10.1016/j.humpath.2022.07.024 2022 EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience. PAX5
72 36032657 10.3389/pore.2022.1610482 2022 The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma. PAX5
73 36077495 10.3390/ijms231710095 2022 The Pleiotropy of <i>PAX5</i> Gene Products and Function. PAX5
74 31935288 10.1182/bloodadvances.2019000947 2021 Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas. PAX5
75 32161948 10.1093/gigascience/giaa016 2021 An image dataset related to automated macrophage detection in immunostained lymphoma tissue samples. PAX5
76 32202217 10.1177/0300985820906889 2021 Equine Intestinal Lymphoma: Clinical-Pathological Features, Immunophenotype, and Survival. PAX5
77 32202225 10.1177/0300985820913265 2021 Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors. PAX5
78 32235787 10.3390/ijms21062193 2021 The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia. PAX5
79 32245383 10.1186/s12920-020-0709-y 2021 Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL. PAX5
80 32368831 10.1002/gcc.22858 2021 Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16. PAX5
81 32420699 10.1002/cam4.3136 2021 Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. PAX5
82 32590454 10.1097/PAI.0000000000000863 2021 Aberrant Cytoplasmic Terminal Deoxynucleotidyl Transferase (TdT) Immunostaining on Previously Frozen, Formalin-fixed Paraffin-embedded Tissue: Cryotomy-induced Antigen Diffusion (CIAD). PAX5
83 32592278 10.1002/gcc.22882 2021 Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol. PAX5
84 32622430 10.1016/j.acthis.2020.151548 2021 Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment. PAX5
85 32646889 10.3324/haematol.2020.250423 2021 DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. PAX5
86 32684618 10.12659/AJCR.921840 2021 Primary Isolated Lymphoplasmacytic Lymphoma (LPL) of the Stomach: A Case Report. PAX5
87 32693409 10.1182/blood.2020006164 2021 Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. PAX5
88 32731299 10.1111/bjh.17002 2021 High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse. PAX5
89 32769356 10.4103/IJPM.IJPM_343_18 2021 High-grade transformation in nodular lymphocyte predominant Hodgkin lymphoma. PAX5
90 32911536 10.1182/blood.2019004381 2021 An intact gut microbiome protects genetically predisposed mice against leukemia. PAX5
91 32991677 10.5858/arpa.2020-0135-OA 2021 CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center. PAX5
92 33004416 10.1101/gad.340216.120 2021 EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism. PAX5
93 33036026 10.1182/blood.2020005756 2021 Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia. PAX5
94 33038982 10.1016/j.beha.2020.101193 2021 Molecular markers in ALL: Clinical implications. PAX5
95 33079423 10.1111/pin.13038 2021 Mantle cell lymphoma with EBV-positive Hodgkin and Reed-Sternberg-like cells in a patient after autologous PBSCT: Phenotypically distinct but genetically related tumors. PAX5
96 33094664 10.1080/15476286.2020.1838783 2021 LncRNAs in adaptive immunity: role in physiological and pathological conditions. PAX5
97 33154497 10.1038/s41598-020-76206-y 2021 Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis. PAX5
98 33206936 10.1182/blood.2020005650 2021 Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. PAX5
99 33357483 10.1016/S2352-3026(20)30353-7 2021 Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study. PAX5
100 33369444 10.31557/APJCP.2020.21.12.3493 2021 Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis. PAX5